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NKR-PIA Is a Target-specific Receptor That Activates 
Natural Killer Cell Cytotoxicity 
By James C. Ryan, Er6ne C. Niemi,  Mary  C. Nakamura,  
and Wi l l iam E. Seaman 
From the Department of Medicine, University of California, San Francisco, San Francisco, 
California 94143; and the Veterans Administration Medical Center, San Francisco, California 94121 
SUmlTlary 
NKR-P1A is a lectinlike surface molecule xpressed on rat natural killer (NK) cells. NKR-P1A 
has structural and functional features of an activating NK cell receptor, but a requirement for 
NKR-P1A in target cell lysis has not been determined. To define the role of NKR-PIA in natural 
killing, we have generated a mutant of the rat NK cell line, RNK-16, lacking expression of 
all members of the NKR-P1 receptor family. Although these NKR-Pl-deficient NK cells were 
able to kill many standard tumor targets, including YAC-1, they were selectively deficient in 
the lysis of IC-21 macrophage, B-16 melanoma, and C1498 lymphoma targets. Reexpression 
of a single member of the NKR-P1 family, NKR-PIA, on mutant cells restored lysis of IC-21, 
and killing of IC-21 targets through rat NKR-PlA was completely blocked by F(ab')2 anti- 
NKR-PLA. Reexpression fNKR-PIA also restored transmembrane signaling to IC-21, as assessed 
by the generation of inositol-l,4,5-trisphosphate. Thegeneration of inositol-l,4,5-trisphosphate 
was also restored in response to B-16 targets, but both B-16 and C1498 cells remained resistant 
to lysis, indicating that other NK cell molecules, perhaps within the NKR-P1 family, are required 
for the efficient killing of these tumors. These results are the first to demonstrate hat NKR-PIA 
is a target-specific receptor that activates natural killing. 
N 'K cells are large granular lymphocytes that spontane- ously lyse certain tumors, vitally infected cells, and blast 
cells. The receptors on NK cells that recognize target cells 
and thereby activate NK cells have not been defined (1). In 
rats, candidates include the lectinlike molecules NKR-PIA, 
which can activate NK cell cytotoxicity (2, 3). The NKR-P1 
receptor family was defined by NKtL-P1A, a 60-kD type II 
integral membrane homodimer with an extracellular calcium- 
dependent (C-type) lectin domain (2-4). NKR-PIA is one 
member of a family of receptors, at least three in number, 
identified by cDNA cross-hybridization (5,6). mAb to NKR- 
P1A (3.2.3) binds to all rat NK cells and stimulates NK cyto- 
toxicity, phosphoinositide turnover, calcium mobilization, and 
degranulation (2, 7). The importance of NKtL-P1A in tumor 
lysis, however, is yet to be determined. A physiologic ligand 
for NKR-PIA has not been identified, and mAb to NKR- 
PIA does not block cytotoxicity against standard targets uch 
as YAC-1 (2, 7). 
To define the role of NKR-PIA in natural killing, we have 
used the rat NK cell line R.NK-16, which expresses NKR- 
PIA (7). After treatment of RNK-16 cells with the mutagen 
ethylmethane sulfonate, we isolated a variant cell line that 
lacked surface xpression of NKR-P1A and, by Northern blot 
analysis, lacked transcripts for all members of the NKR-P1 
family. Functional studies using this NKR-PlA-deficient 
mutant line demonstrate hat NKR-P1A is a target-specific 
receptor that activates natural killing. 
Materials and Methods 
Antibodies. mAb 3.2.3 (anti-NKR-PlA), 3G7 (anti-gp42), and 
B22.249 (anti-H-2D b, cxl/cx2) were produced as ascites and were 
partially purified by precipitation i  50% saturated ammonium 
sulfate at 4~ for 18 h followed by dialysis against PBS. F(ab')2 
fragments were produced as previously described (7), and F(ab')2 
preparations were analyzed for completeness of digestion by SDS- 
PAGE. 
Cell Lines. RNK-16, an NK cell leukemia line from F344 rats, 
was a gift from Craig Reynolds (National Cancer Institute, Na- 
tional Institutes of Health, Frederick, MD) (7). The MHC class I
transfectants of C1498, termed C1498.D12, C1498.K18, C1498.D8, 
were reported previously (8) and were provided by Wayne Yoko- 
yama nd Franz Karlhofer (Mount Sinai Medical Center, New York), 
as were the tumor targets KF.9, RBL-5, and RMA-S. The 51B colon 
carcinoma line (9) was obtained from Robert Bresalier (Henry Ford 
Hospital, Detroit, MI). The B-16 melanoma line was from Klas 
K~rre (Karolinska Institute, Stockholm, Sweden). The B22.249 hy- 
bridoma was supplied by David Raulet (University of California, 
Berkeley, CA). The PA317 and the ~z retroviral packaging lines 
were from Dan Littman (University of California, San Francisco, 
CA). All other tumors were obtained from the American Type Cul- 
ture Collection (Rockville, MD). All cells were grown in corn- 
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plete RPMI (RPMI 1640, 10% fetal bovine serum, penicillin [100 
U/ml], streptomycin [100 #g/ml], glutamine [2 raM], and 2-ME 
[50/zM]) at 37~ in a humidified 5% CO2 atmosphere. 
Preparation of Murine Blast Targets. Con A-stimulated blast cells 
were generated as described (10). Fresh murine splenocytes were 
adjusted to 2 x 106 cells/ml and cultured for 2-3 d in complete 
RPMI supplemented with 5/zg/ml of Con A. Before use as targets, 
cells were collected on Ficoll to remove dead cells. 
Generation of NKR-PIA-deficient Mutants of RNK-16. RNK- 
16.M13 mutants were derived as previously described (11). RNK-16 
cells were treated with ethylmethane sulfonate (200 #g/ml) in com- 
plete RPMI for 24 h. Cells were washed, and then allowed to grow 
for 3 d. They were then selected against he expression of the 3.2.3 
(NKR-P1A) antigen by flow sorting. After five rounds of negative 
selection, NKR-PlA-negative cells were cloned and then subcloned 
to limiting dilution. The cell surface phenotype of each clone was 
determined, and several clones were analyzed for NKR-P1 mRNA 
expression. 
Northern Blot Analysis. Poly(A) + RNA was prepared by a vari- 
ation of the mRNA isolation protocol (Fast Track; Invitrogen, San 
Diego, CA) according to the manufacturer's in tructions. 2/zg of 
poly(A) § RNA from each cell line was analyzed by Northern blot 
analysis according to standard methods (12). The RNA was resolved 
by gel electrophoresis and transferred toa nitrocellulose membrane. 
A 32p-radiolabeled full-length rat NKR-PIA cDNA probe was 
generated using ~-[32p]dCTP (3,000 Ci/mmol, Amersham Corp., 
Arlington Heights, IL) by using the Random Hexanucleotide Primer 
Labeling kit (Boehringer Mannheim Corp., Indianapolis, IN) ac- 
cording to the manufacturer's instructions. Afterprehybridization, 
the membrane was incubated with the probe overnight at 42~ 
in hybridization solution (50% formamide, 6x SSC, 5x Denhardt's, 
1% SDS, and 50/xg/ml salmon sperm DNA) as described (12). 
The membrane was then washed at progressively higher stringency, 
with the final wash in 0.25x SSC, 0.1% SDS, at 42~ As a con- 
trol, the blot was stripped by treatment with 1 mM EDTA at 95~ 
for 15 rain and reprobed with the glyceraldehyde-phosphate de- 
hydrogenase (GAPDH) cDNA. 
Transfection fRNK-16.M13 witk the Rat NKR-P1A cDNA. 
Reconstitution ofNKR-PIA expression i RNK-16.M13 mutants 
was accomplished using the retroviral gene transfer system as de- 
scribed (13). Briefly, the full-length rat NKR-PIA cDNA was sub- 
cloned into the EcoRI site of the pMV7 expression vector, which 
was then transfected into the packaging cell line ~ by using cal- 
cium phosphate precipitation (12). After 48 h, culture supernatants 
were used to infect PA317 packaging cells in 100-mm dishes in the 
presence of polybrene (8 #g/ml) for 2 h. Stably transfected PA317 
packaging lines were generated by selection in G418 (250/~g/ml 
in complete RPMI). Supernatants from NKR-PIA-transfected 
PA317 cells were incubated with RNK-16.M13 cells in the pres- 
ence of polybrene. After 2 d, the RNK-16.M13 cells were selected 
in 300/zg/ml of G418 in complete RPMI. NKR-PIA-expressing 
cells were isolated and subcloned after ,,020 d in selection. One 
clone, RNK-16.T18, exhibited a phenotype characteristic ofall high 
expressing transfectants. 
Cytotoxicity Assays. Cytotoxicity was measured by using SlCr- 
release microcytotoxicity assays as previously described in detail (7). 
For antibody-blocking studies, F(ab')2 fragments (50/~g/106 effec- 
tors) were added to effectors at 20~ 15 min before assays. 
Assays for Pkospkoinositide Turnover. Assays for inositol-l,4,5- 
trisphosphate (InsP3) were performed exactly as described (7). 
Briefly, duplicate samples of 5 x 106 [3H]inositol-labeled NK cells 
were stimulated with 107 targets in a total volume of I ml. The 
cells were rapidly pelleted and resuspended in 1 ml of 10% TCA. 
The [3H]InsP3 from each sample was extracted with diethyl ether 
and resolved by ion exchange chromatography on Dowex Ag 1-X8 
(Bio-Rad Laboratories, Hercules, CA). 
Results and Discussion 
RNK-16 cells were treated with the mutagen ethylmethane 
sulfonate and sdected against the surface expression of rat 
NKR-P1A. Eight cloned cell lines lacked detectable surface 
expression of NKR-PLA. One line, RNK-16.M13, also lacked 
detectable mRNA transcripts for all members of the NKR-Pl  
family (Fig. 1). RNK-16.M13 expressed other surface mole- 
cules at normal evels, including CD2, CD45, and gp42 (not 
shown). 
RNK-16.M13 lysed most tumor targets, including YAC-1, 
with approximately the same effidency as the parent line (Table 
1). Three targets that were susceptible to lysis by RNK-16, 
however, were not lysed by RNK-16.M13:IC-21 macrophage, 
C1498 lymphoma, and B-16 melanoma cells. Similar results 
were obtained with the seven other mutant RNK-16 clones 
that lacked NKR-PlA (not shown). Of  note, IC-21, C1498, 
and B-16 were all derived from C57BL/6 mice (H-2b), and 
they were the only H-2 b targets that were killed by wild- 
type RNK-16. Tumors from H-2 a or from (1-I-2 b x H-2a)F1 
mice were lysed equally by the parent and mutant cell lines, 
and transfection of H-2 b C1498 lymphoma cells with the 
cDNAs encoding H-2D d, H-2K d, or H-2L a did not alter 
their susceptibility to lysis by either line. The H-2 b tumor 
target RBL-5 and its MHC-deficient mutant, RMA-S (14), 
were uninformative, since neither was lysed by RNK-16 or 
RNK-16.M13 ceils, nor were T call blast targets from either 
C57BL/6 (H-2 b) or BALB/c (H-2 d) mice. 
The expression of NKR-PlA, the most abundant member 
of the NKR-P1 family, was restored on RNK-16.M13 cells 
by retroviral gene transfer. A cloned line, RNK-16.T18, 
expressed NKR-P1A at a level similar to that on parental 
RNK-16 calls (Fig. 2). The killing of informative targets by 
RNK-16.T18, RNK-16.M13, and RNK-16 cells was exam- 
Figure 1. Northern blot analysis of 
RNA from wild-type RNA-16 and the 
NKR-Pl--deficient mutant RNK-16.M13. 
When probed with the full-length (1.0 
kb) rat NKR-PLA cDNA, wild-type 
RNA-16 expresses 1.1 kb, 1.7 kb, and 2.4 
kb NKR-Pl-related mRNA species. 
RNK-16.M13, however, expresses no 
NKR-P1 transcripts. Both cells express 
similar amounts of control GAPDH 
mRNA. 
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Table 1. Lysis of Murine Target Cells by RNK-16 and RNK-16.M13 
RNK-16 RNK-16.M13 
Cell line Type H-2 40 20 10 5 40 20 10 5 
E/T ratio E/T ratio 
YAC-1 Lymphocytes a 69 64 56 43 44 36 30 18 
RLo" 1 Lymphoma d 69 64 51 38 65 64 49 30 
P388.D1 Macrophage d 71 58 51 37 27 18 12 8 
51B Carcinoma d 46 41 36 29 42 38 34 25 
RAW.309 Macrophage b • d 20 19 17 12 13 6 4 3 
IC-21 Macrophage b 30 27 23 19 6 5 6 6 
B-16 Melanoma b 28 23 17 13 5 4 4 4 
C1498 Lymphoma b 31 30 24 17 0 0 0 0 
C1498.D12 Lymphoma b + D a 49 43 34 21 0 0 0 0 
C1498.K18 Lymphoma b + K a 38 33 25 17 0 0 0 0 
C1498.L8 Lymphoma b + L d 39 37 28 18 0 0 0 0 
KF.9 Lymphoma b 6 5 3 2 0 0 0 0 
TIMI.4 Lymphoma b 1 1 1 1 2 2 2 1 
RBL 5 Lymphoma b 1 2 1 3 0 0 0 0 
RMA-S Lymphoma b- 1 1 1 0 0 0 0 0 
P815 Mastocytoma d 9 7 4 1 2 1 1 0 
R1.1 T cell k 2 3 3 1 0 0 1 0 
BW5147.3 T cell k 4 5 6 5 4 3 3 2 
BALB/c T blast* d 5 3 1 1 0 0 0 0 
C57BL/6 T blast* b 4 3 3 1 0 0 0 0 
Mutational loss of NKR-P1 by RNK-16 cells is accompanied by loss of cytotoxicity against selected targets. Lysis of most targets by RNK-16 and 
NKR-Pl-deficient RNK-16.M13 was similar. NKR-Pl-deficient RNK-16.M13, however, was selectively unable to kill IC-21, B-16, and C1498. 
Transfection of C1498 with the cDNAs encoding H-2D d (C1498.D12), H-2K d (C1498.K18), or H-2L d (C1498.L8) did not alter susceptibility to 
lysis by either effector. RBL-5 and its MHC class I-deficient mutant, RMA-S (8), were uninformative targets, since neither was killed. Lysis of 
all tumor targets was examined at E/T ratios of 40:1, 20:1, 10:1, and 5:1. 
* For T cell blast targets, effectors were added at E/T ratios of 100:1, 50:1, 25:1, and 12.5:1. 
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Figure 2. NKR-PIA-specific ell surface staining of wild-type RNK- 
16, RNK-16.M13, and RNK-16.T.18 by flow cytometry. R.NK-16.M13 
mutant cells (M.13)  express no cell surface NKR-PIA as determined by 
staining with the 3.2.3 mAb. NKIL-PIA-transfected mutants ILNK-16.T18 
(T18 ,  shaded) express NKR-PIA at levels comparable to those of wild- 
type RNK-16 (WT). Expression of CD45, CD2, and gp42 was similar 
ined (Fig. 3, A-D). Killing of YAC-1 targets by RNK-16.T18 
was equal to killing by RNK-16.M13 cells. (In the experi- 
ment presented, killing of YAC-1 by both lines was less than 
by RNK-16, but this was not regularly the case.) Killing 
of IC-21 cells, not seen with RNK-16.M13 cells, was sub- 
stantially restored by expression of NKR-PIA on RNK-16.T18 
cells. Thus, NKR-P1A is necessary and sufficient for lysis 
of IC-21. Other members of the NKR-P1 family, however, 
might also have this capability. In support of this, F(ab~ 
antibody to NKfL-P1A completely blocked killing of IC-21 
by RNK-16.T18 cells, but it had no effect on killing of IC-21 
by parent RNK-16 cells, which express all members of the 
in all lines (not shown). None of the cell lines stained with various control 
antibodies, including antibodies against rat CD3 (not shown). 
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Figure 3. Cytotoxicity (A-F) by 
wild-type RNK-16, RNK-16.M13, 
and RNK-16.T18 cells. NK cell 
cytotoxicity was tested against 
YAC-1 (A), C1498 (B), B-16 (C), 
and IC-21 (D-F) tumors. YAC-1 
(.4) was killed by wild-type KNK- 
16 (O), RNK-16.M13 mutant cells 
(0),  and by NKR-PlA-transfected 
RNK-16.T18 (ll). C1498 (B) was 
lysed by RNK-16, not by RNK- 
16.M13, and weakly by KNK- 
16.T-18. B-16 (C) was lysed by 
RNK-16, not by RNK-16.M13, and 
not by RNK-16.T18. IC-21 (D) was 
killed by RNK-16, and not by 
RNK-16.M13, but was lysed by the 
RNK-16.T18 transfectants. Ly~is of 
IC-21 by RNK-16 (O, E) was not 
blocked by F(ab')2 3.2.3 (A, E). 
Killing of IC-21 by RNK-16.T18 
( i ,  F), however, was completely 
blocked by F(ab')2 3.2.3 (A, F), 
but not by F(ab')2 B22.249 (anti- 
H-2D b, cq/t~z) or F(ab')2 3G7 
(anti-gp42) (not shown). 
NKR-P1 family (Fig. 3, E-F). We conclude that NKR-P1A 
is a specific receptor for IC-21 but that other members of 
the NKR-P1 family can also serve this function. 
Killing of C1498 or B-16 cells, in contrast to IC-21 cells, 
was not substantially restored by expression of NKR-PIA; 
in each of three experiments, killing was either absent or was 
only slightly above baseline (Fig. 3, B and C). Thus, NKR- 
P1A alone cannot significantly restore the lyric response to 
these two targets. 
As another assay for the NK response to targets, we next 
examined polyphosphoinositide turnover, an early transmem- 
brahe signal in NK cell activation (7). The generation of 
InsP3 by RNK-16 cells in response to target cells was com- 
pared to the generation of InsP3 by RNK-16.M13 and 
RNK-16.T18 cells (Fig. 4, A-C). All three NK cell lines 
demonstrated a brisk response to YAC-1, consistent with the 
demonstration that NKR-PIA is not required for lysis of this 
target. Both IC-21 and B-16 cells stimulated a response in 
RNK-16 cells that was absent in RNK-16.M13 cells and was 
restored in RNK-16.T18 cells. The response to C1498 was 
too low in all cell lines to detect significant changes. The 
response to IC-21 is thus concordant with cytotoxicity, but 
NKR-P1A restores the inositol response to B-16 without 
restoring killing. Additional signals are apparently needed for 
lysis of B-16, perhaps supplied by other members of the 
NKR-P1 family. 
The NKR-P1 gene family is part of a superfamily of lec- 
tinlike receptors that are genetically linked (15-18). In the 
mouse, these include the Ly-49 family, whose ligands include 
class I MHC antigens. Ly-49A binds to H-2D a and, in con- 
trast to NKR-P1A, inactivates cytotoxicity (8, 19, 20). The 
specificity of Ly-49A for class I MHC antigens and the in- 
ability of RNK-16.M13 cells to lyse H-2 b targets raised the 
possibility that NKR-P1A might specifically recognize class 
I MHC antigens of the H-2 b haplotype. Lysis of these 
targets, however, was not blocked by F(ab')2 antibody to the 
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Figure 4. Tumor-induced lnsP3 
generation by RNK-16 (tl), RNK- 
16.M13 (B), and RNK-16.T18 (C). 
NK cell lines were stimulated with 
VAC-1 (e), ]c-21 (B), Bq6 (A), 
C1498 (A), or medium alone (I-l). 
RNK-16 (A) responded briskly to 
YAC-1 (0), IC-21 (.) ,  and B-16 
(A), and responded weakly to 
C1498 (&). RNK-16.M13 (B) was 
stimulated by YAC-I, but not by 
IC-21, B-16, or C1498. RNK-16.T18 
(C) was stimulated byYAC-1, IC-21, 
and B-16, and was minimally stimu- 
lated by C1498. Thus, NKR-PIA restores inositol signaling in response to IC-21, and it restores inositol signaling but not killing in response to B-16. 
Signaling in response to C1498 by all three NK cell lines was too low to detect significant changes. 
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0ll/0/2 domain of the H-2D b allele, and not all H-2 b targets 
were killed by NKR-1A + cells (Table 1). Also, recent studies 
of human NK clones have not shown acorrelation between 
response to class I antigens and the expression of a human 
homologue of NKR-PIA (18). Resolution of this issue will 
require isolation of the ligands for NKR-PIA. Although a 
physiologic ligand for NKR-PLA has not yet been fully charac- 
terized, soluble preparations of the rat NKR-PIA lectin do- 
main can bind to specific monosaccharides and neoglycocon- 
jugates (4). IC-21 targets should be a fruitful source for 
characterization f a natural igand for NKR-P1A. 
Our studies are the first to demonstrate a target-specific 
receptor that activates natural killing. The superfamily oflec- 
tinlike receptors on NK cells thus includes sped fie receptors 
that can either activate (NKR-P1) or inhibit (Ly-49) lysis by 
NK cells in response to specific ligands on target cells. The 
NKR-P1 family appears to provide specificity for only a limited 
range of targets. It is likely that other specific receptors re- 
main to be identified, perhaps within the superfamily of NK 
lectinlike receptors. 
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